These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 37257331)
21. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma. Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D Front Immunol; 2022; 13():918140. PubMed ID: 35833147 [TBL] [Abstract][Full Text] [Related]
22. Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. Huang Y; Zhang W; Li Q; Wang Z; Yang X Sci Rep; 2023 Mar; 13(1):3661. PubMed ID: 36871072 [TBL] [Abstract][Full Text] [Related]
23. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer. Zheng J; Guo J; Cao B; Zhou Y; Tong J Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292 [TBL] [Abstract][Full Text] [Related]
24. m6A- and m5C- modified lncRNAs orchestrate the prognosis in cutaneous melanoma and m6A- modified LINC00893 regulates cutaneous melanoma cell metastasis. Shi HZ; Tian CC; Wu MY; Ma L; Sun JF; Chen H Skin Res Technol; 2024 Jul; 30(7):e13842. PubMed ID: 38965799 [TBL] [Abstract][Full Text] [Related]
25. Molecular Characterization of Cuproptosis-related lncRNAs: Defining Molecular Subtypes and a Prognostic Signature of Ovarian Cancer. Li N; Yu K; Huang D; Li S; Zeng D; Li J; Fan L Biol Trace Elem Res; 2024 Apr; 202(4):1428-1445. PubMed ID: 37528285 [TBL] [Abstract][Full Text] [Related]
26. Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis. Liu HT; Rau CS; Liu YW; Hsieh TM; Huang CY; Chien PC; Lin HP; Wu CJ; Chuang PC; Hsieh CH J Hepatocell Carcinoma; 2023; 10():2383-2395. PubMed ID: 38164510 [TBL] [Abstract][Full Text] [Related]
27. A novel m6A/m5C/m1A score signature to evaluate prognosis and its immunotherapy value in colon cancer patients. Liu J; Dou M; Liu X; Lu Y; Lu W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11995-12012. PubMed ID: 37421455 [TBL] [Abstract][Full Text] [Related]
28. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Zhao J; Lin X; Zhuang J; He F Front Genet; 2021; 12():714697. PubMed ID: 34777460 [No Abstract] [Full Text] [Related]
29. Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature. Zhang L; Liu C; Zhang X; Wang C; Liu D Funct Integr Genomics; 2023 Apr; 23(2):117. PubMed ID: 37014493 [TBL] [Abstract][Full Text] [Related]
30. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma. Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136 [TBL] [Abstract][Full Text] [Related]
31. Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas. Li Y; Li X; Yu Z Front Oncol; 2023; 13():1177120. PubMed ID: 37228500 [TBL] [Abstract][Full Text] [Related]
32. Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma. Huang F; Wang X; Zhong J; Chen H; Song D; Xu T; Tian K; Sun P; Sun N; Qin J; Song Y; Ma W; Liu Y; Yu D; Meng X; Jiang C; Xuan H; Qian D; Cai J Cancer Cell Int; 2023 Aug; 23(1):156. PubMed ID: 37542290 [TBL] [Abstract][Full Text] [Related]
33. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response. Cao J; Liang Y; Gu JJ; Huang Y; Wang B Front Genet; 2022; 13():991162. PubMed ID: 36353118 [No Abstract] [Full Text] [Related]
34. Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes. Ding H; Teng Y; Gao P; Zhang Q; Wang M; Yu Y; Fan Y; Zhu L Hum Mol Genet; 2024 Mar; 33(7):563-582. PubMed ID: 38142284 [TBL] [Abstract][Full Text] [Related]
35. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq. Li W; Li X; Ma X; Xiao W; Zhang J BMC Genomics; 2022 Feb; 23(1):105. PubMed ID: 35135476 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer. Liu J; Chen C; Wang Y; Qian C; Wei J; Xing Y; Bai J Front Immunol; 2021; 12():746647. PubMed ID: 34777359 [TBL] [Abstract][Full Text] [Related]
37. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma. Yang S; Zhou J; Chen Z; Sun Q; Zhang D; Feng Y; Wang X; Sun Y Front Oncol; 2022; 12():934928. PubMed ID: 35992788 [TBL] [Abstract][Full Text] [Related]
38. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
39. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. Liu Y; Wang T; Fang Z; Kong J; Liu J J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871 [TBL] [Abstract][Full Text] [Related]
40. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]